Depleting HLA-DMA Suppresses Glioblastoma Phenotypes and Enhances Anti-PD-1 Response
Silencing HLA-DMA curbs glioblastoma cell malignancy and remodels tumor macrophages while enhancing anti-PD-1 immunotherapy efficacy in preclinical models.
Silencing HLA-DMA curbs glioblastoma cell malignancy and remodels tumor macrophages while enhancing anti-PD-1 immunotherapy efficacy in preclinical models.
We bring you the latest biotechnology news from best research centers and universities around the world. Check our website.
Bioengineer.org © Copyright 2023 All Rights Reserved.
Bioengineer.org © Copyright 2023 All Rights Reserved.